FIELD: pharmacology.
SUBSTANCE: invention relates to an oral dosage form comprising an amorphous dispersion of {2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl} amide of cyclopropanecarboxylic acid or a pharmaceutically acceptable salt thereof in a hydrophilic polymer, wherein the hydrophilic polymer is hydroxypropylmethylcellulose. Also, methods for treatment, control or prevention of various diseases such as cancer or inflammatory disease are proposed.
EFFECT: creation of a dosage form with rapid disintegration, reduced friability, content uniformity, rheological properties required for production, solubility, bioavailability, stability and desired hardness.
9 cl, 4 dwg, 2 tbl, 1 ex
Title |
Year |
Author |
Number |
FORMULATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE |
2010 |
- Tatino Ehntoni
- Kelli Majkl T.
|
RU2479307C1 |
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE |
2012 |
- Myuller Dzhordzh V.
- Man Khon-Vakh
- Koen Bendzhamin M.
- Li In
- Syuj Dzhin
- Leong Uillyam V.
|
RU2611007C2 |
USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS |
2007 |
|
RU2446804C2 |
CRYSTALLINE FORM OF 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND |
2009 |
- Patterson Lori Dzhin
- Chao Robert
- Rapta Miroslav
|
RU2503662C2 |
METHODS FOR ADMINISTRATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOLE-2-YL)PIPERIDINE-2,6-DIONE IN CERTAIN TYPES OF LEUKEMIA |
2006 |
|
RU2406501C2 |
4, O-SUBSTITUTED ISOINDOLINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM |
2008 |
- Rachelmen Aleksander L.
- Mjuller Dzhordzh V.
- Man Khon-Vakh
|
RU2471794C2 |
METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MAINTENANCE OF CANCER AND OTHER DISEASES |
2004 |
|
RU2348407C2 |
2-S-BENZYLSUBSTITUTED PYRIMIDINES AS CRTH2 ANTAGONISTS |
2008 |
- Laj Taj Vehj
- Potter Garrett T.
- Tran Mari Shantal' S.-I.
|
RU2491279C2 |
CRYSTALLINE (2S,4R)-5-(5'-CHLOR-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOL-5-CARBOXAMIDO)-2-METHYLPENTANIC ACID AND ITS APPLICATIONS |
2017 |
- Hughes, Adam D.
- Fleury, Melissa
- Rapta, Miroslav
- Thalladi, Venkat R.
- Fass, Gene Timothy
- Simeone, Michael
- Baldwin, R. Michael
- Bourdet, David L.
|
RU2756223C2 |
METHOD FOR PRODUCING FUNCTIONAL PROTEIN FROM DNA HAVING NONSENSE MUTATIONS, AND TREATING ASSOCIATED DISORDERS |
2007 |
- Al'Msted Nil G.
- Chen Guangming
- Khiravat Samit
- Khvang Seongvoo
- Karp Gari M.
- Miller Langdon
- Moon Joung-Choon
- Ren Khongiu
- Takasugi Dzhems Dzh.
- Uehlch Ehllen M.
- Uajld Richard Dzh.
- Kennedi Pol
|
RU2462246C2 |